Ophthalmology Science (October 2023) published a Mary Tyler Moore Vision Initiative Working Group paper titled “A New Approach to Staging Diabetic Retinal Disease.” An in-depth review that explores an overview of the existing evidence regarding biomarkers for measuring diabetic retinal disease (DRD), specifically diabetic retinal neurodegeneration and diabetic macular edema. Despite significant progress in retinal diagnostics, particularly in data collection from diabetic patients, the staging of DRD remains reliant on traditional color fundus photographs. There is a lack of clear guidelines on integrating data from newer diagnostic modalities into clinical practice. The lead author is Roomasa Channa, MD, and Michael Abramoff, MD, PhD, on behalf of the Diabetic Retinal Neurodegeneration and Macular Edema working group of MTM Vision and JDRF’s DRD Staging Update Project.
Our Publications>
A New Approach to Staging Diabetic Retinal Disease
Latest news
News
Variety Announces: The Mary Tyler Moore Vision Initiative Launches Diabetes Research PSA Campaign With Kevin Kline, Oprah Winfrey, Julia Louis-Dreyfus
Read more
News
MTM Vision’s Founder and CEO, Dr. S. Robert Levine is featured in "Leaders" Magazine
Read more
News
Kristen Wiig Receives The Inaugural Mary Tyler Moore Visionary Award
Read more
Join Our Email List
By submitting this form, you are consenting to receive marketing emails from: Mary Tyler Moore Vision Initiative. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact